Eli Lilly and Company - Diluted EPS

Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in USD.

The item "Diluted-EPS" stands at 20.45 United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value at least since 03/31/2012, the period currently displayed.

Eli Lilly and Company's third quarter result of 6.21 USD for the item "Diluted EPS" represents a decrease of -1.27 percent compared to it's second quarter result.

Also, Eli Lilly and Company's third quarter result of 6.21 USD for the item "Diluted EPS" represents an increase of 479.31 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Eli Lilly and Company's third quarter result of 20.45 USD for the item "Diluted EPS" represents an increase of 33.57 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 11.19 United States Dollars compared to the value the year prior.
The 1 year change is 11.19 United States Dollars.
The 3 year change is 13.98 United States Dollars.
The 5 year change is 14.62 United States Dollars.
The 10 year change is 18.32 United States Dollars.

The Serie's long term average value is 5.13 United States Dollars. It's latest available value, on 09/30/2025, is 15.32 United States Dollars higher, compared to it's long term average value.
The Serie's change in United States Dollars from it's minimum value, on 12/31/2017, to it's latest available value, on 09/30/2025, is +20.70 .
The Serie's change in United States Dollars from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0 .